20403 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
#602Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
#603Hydroxyl-polymer-drug-protein conjugates
#604BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
#605Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
#606ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
#607Method for the preparation of liposome encapsulated vincristine for therapeutic use
#608Solid dispersion with improved solubility comprising tetrazole derivative as an active ingredient
#609Means and method for treating solid tumors
#610Oral dosage forms of bendamustine and therapeutic use thereof
#611Methods and Models for Determining Likelihood of Cancer Drug Treatment Success Utilizing Predictor Biomarkers, and Methods of Diagnosing and Treating Cancer Using the Biomarkers
#612TREATMENT OF AUTOPHAGY-BASED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTIC AND SCREENING ASSAYS AND KITS
#613Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues
#614NON-PEGYLATED LIPOSOMAL DOXORUBICIN COMBINATIONS FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
#615Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
#616Combination therapies using HDAC inhibitors
#617Lymphoma prognostic methods and kits
#618Methods for identifying and treating cancer patients
#619METHODS FOR SCREENING MUSCLE INVASIVE BLADDER CANCER PATIENTS FOR NEOADJUVANT CHEMOTHERAPY RESPONSIVENESS
#620Liposomes useful for drug delivery
#621KITS AND METHODS FOR SUSTAINED WEIGHT LOSS
#622COMBINATION OF SYROSINGOPINE AND MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOSUPPRESSION
#623Combination therapy for the treatment of cancer and immunosuppression
#624Methods for treatment of Parkinson's disease
#625Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent
#626NOVEL BIFUNCTIONAL METNASE/INTNASE INHIBITORS AND RELATED COMPOSITIONS AND METHODS OF TREATMENT OF CANCER
#627Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#628Agents and methods for treating and preventing seborrheic keratosis
#629SPINAL NEUROMODULATION AND ASSOCIATED SYSTEMS AND METHODS
#630Compositions of combinations of non-covalent DNA binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment
#631Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
#632Cholecystokinin B receptor targeting for imaging and therapy
#633Methods and compositions for the treatment of proliferative disorders
#634Use of inhibitors of Bruton's tyrosine kinase (Btk)
#635Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
#636Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt
#637Small molecule compounds to treat hearing loss
#638Methods of treating urothelial carcinoma
#639Folate receptor alpha binding ligands
#640Compounds and methods for treating leukemia
#641Poxviral oncolytic vectors
#642Compounds For Reducing Drug Resistance And Uses Thereof
#643Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone
#644Triazole compounds that modulate HSP90 activity
#645Methods and compositions for promoting activity of anti-cancer therapies
#646Drug loaded polymeric nanoparticles and methods of making and using same
#647Methods and Compositions for Treating a Disease Condition in a Subject
#648Histone deacetylase (HDAC) inhibitors for the treatment of cancer
#649Combination of CRTH2 Antagonist and a Proton Pump Inhibitor for the Treatment of Eosinophilic Esophagitis
#650CHEMOTHERAPEUTIC FOR INDUCING AN MSH2 DEPENDENT APOPTOTIC PATHWAY
#651Use of opioid antagonists to attenuate endothelial cell proliferation and migration
#6521,4-dihydropyridine derivatives with Hsp modulating activity
#653Compositions and methods for drug-sensitization or inhibition of a cancer cell
#654TOPOISOMERASE INHIBITORS AND METHODS OF MAKING AND USE AS THERAPEUTIC AGENTS
#655METHODS AND COMPOSITIONS FOR THE TREATMENT OF OVARIAN CANCER
#656Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
#657Treatment agent and/or prophylactic agent for side effects of cancer drugs
#658Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
#659Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones
#660Small chemical compound which promotes induction of differentiation of stem cells into insulin-producing cells and method for inducing differentiation of stem cells into insulin-producing cells using said small chemical compound
#661Use of deoxyelephantopin (DET) and analogues thereof for reducing side effects of an anti-cancer agent
#662Compounds and methods of treating ocular disorders
#663LUNG CANCER BIOMARKERS
#664Soluble protein CD5 or CD6 for the treatment of cancer or tumor or for use as an adjuvant
#665Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent
#666Methods for treating amyloidosis with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
#667Use of inhibitors of bruton's tyrosine kinase (BTK)
#668INDIBULIN THERAPY
#669Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with antibodies
#670Methods and compositions relating to P62 for the treatment and prophylaxis of cancer
#671Liposomes useful for drug delivery
#672Methods of treating giardiasis
#673Methods and compounds for treating cancer
#674Selective androgen receptor modulator for treating hormone-related conditions
#675Antineoplastic combinations containing HKI-272 and vinorelbine
#676TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
#677PARP INHIBITORS FOR THE TREATMENT OF CIPN
#678Uses of an immunomodulatory protein (GMI) from
#679Methods and compositions for the treatment of proliferative disorders
#680Formulations of water-insoluble chemical compounds and methods of using a formulation of compound FL118 for cancer therapy
#681COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXITY (ADCC)
#682Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair
#683PHARMACEUTICAL COMPOSITION OF VINFLUNINE WHICH IS INTENDED FOR PARENTERAL ADMINISTRATION PREPARATION METHOD THEREOF AND USE OF SAME
#684Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
#685Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
#686Methods and pharmaceutical compositions for inhibiting influenza viruses replication
#687Method for treatment of neurologic dysfunction
#688Anti-DR5 antibodies, polynucleotides and methods
#689Formulations for the prevention and treatment of Wolbachia-related disease
#690ITE for cancer intervention and eradication
#691Indole alkaloid compounds as melanogenesis promoters and uses thereof
#692Uses of an immunomodulatory protein (GMI) from
#693Medicament comprising recombinant antibody against chemokine receptor CCR4
#694Treatment of solid tumors with rapamycin derivatives
#695Block copolymers for stable micelles
#696METHODS AND COMPOSITIONS FOR PROMOTING ACTIVITY OF ANTI-CANCER THERAPIES
#697Highly soluble salt of pyrroloquinoline quinone and method for producing the same
#698Pharmaceutical composition and method of treating a microbial infection with sulcotidil
#699Drug loaded polymeric nanoparticles and methods of making and using same
#700Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide or pharmaceutically acceptable salt(s) thereof
#701Use of inhibitors of Bruton's tyrosine kinase (Btk)
#702Compositions and methods of treatment of cancer
#703Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
#704Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with proteasome inhibitor
#705Antibody induced cell membrane wounding
#706Compounds for stem cell differentiation
#707Antibody therapy
#708ANTICANCER COMBINATION TREATMENTS
#709Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
#710Methods of treating obstructive lung diseases using bitter tastants
#711Synergistic Anti-Cancer Activity of SR16388 with Anti-Mitotic Drugs
#712Liposomes useful for drug delivery
#713Peptide for use in the treatment of breast cancer and/or bone metastases
#714Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
#715INDIBULIN THERAPY
#716TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
#717Methods for treatment of Parkinson's disease
#718LIPOSOMES COMPRISING AMPHIPATHIC DRUGS AND METHOD FOR THEIR PREPARATION
#719Long circulating nanoparticles for sustained release of therapeutic agents
#720METHODS FOR REDUCING VEIN IRRITATION
#721EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#722METHODS OF TREATING MESOTHELIOMA WITH A PI3K INHIBITOR COMPOUND
#723Bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
#724COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC)
#725Alkanoylamino benzamide aniline HDAC inhibitor compounds
#726Ceramide anionic liposome compositions
#727Drug loaded polymeric nanoparticles and methods of making and using same
#728Treatment of solid tumors with rapamycin derivatives
#729Melonine bisindole compounds, pharmaceutical compositions, preparation method and use thereof
#730Drug loaded polymeric nanoparticles and methods of making and using same
#731Antineoplastic Combinations Containing HKI-272 and Vinorelbine
#732MicroRNA-140-5p as a tumor suppressor and sensitizing agent for chemotherapy
#733PARP INHIBITORS FOR THE TREATMENT OF CIPN
#734Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibodies
#735COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#736COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#737COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#738Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor
#739Methods for treating amyloidosis using 4-(amino)-2-(2,6-Dioxo(3-piperidyl))- isoindoline-1,3-dione
#740FGFR1 extracellular domain combination therapies for lung cancer
#741Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4Hquinazolin-3-yl)-piperidine-2,6-dione
#742ITE for cancer intervention and eradication
#743Treatment of solid tumors with rapamycin derivatives
#744TREATMENT OF ONCOLOGICAL DISEASES
#745CEPHALOTAXINE ALKALOID COMPOSITIONS AND USES THEREOF
#746Use of Flubendazole and Vinca Alkaloids for Treatment of Hematological Diseases
#747Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt
#748VIRAL MODULATORS AND PROCESSES THEREOF
#749Viral Modulators and Processes Thereof
#750Use of inhibitors of bruton's tyrosine kinase (Btk)
#751APPARATUS AND METHOD FOR FRAME CRIMPING
#752Liposomes useful for drug delivery
#753COMPOSITIONS AND METHODS FOR TREATING LYMPHOMA
#754Methods and compositions using racemic, (R)-, and (S)-fexofenadine in combination with leukotriene inhibitors
#755Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
#756COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER
#757Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
#758THE USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#759USE OF ALKANOYL L-CARNITINE IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF NEOPLASMS
#760ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES RECOGNIZING SPECIFICALLY CD38 AND CYTARABINE
#761USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#762Cancer treatment method
#763Methods for reducing vein irritation
#764Use of deoxyelephantopin (DET) and analogues thereof for treatment of melanoma
#765Nano-Emulsion Injection of Vinca Alkaloids and the Preparation Method Thereof
#766Methods of treating pain
#767Antibody therapy
#768METHODS OF TREATING MULTIPLE MYELOMA USING MELPHALAN, PREDNISONE AND LENALIDOMIDE
#769Compounds for reducing drug resistance and uses thereof
#770COMPOSITIONS FOR POTENTIATING APOPOSIS SIGNALS IN TUMOUR CELLS
#771LIPOSOMES FOR DRUG DELIVERY AND METHODS FOR PREPARATION THEREOF
#772COMPOSITIONS AND METHODS FOR TREATING LYMPHOMA
#773Triazole compounds that modulate HSP90 activity
#774DOWN-REGULATION OF COLD SHOCK PROTEINS FOR CANCER TREATMENT
#775Cancer Treatment Method
#776Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
#777Antitumor combinations containing antibodies recognizing specifically CD38 and vincristine
#778Drug loaded polymeric nanoparticles and methods of making and using same
#779Use of opioids or opioid mimetics for the treatment of resistant cancer patients
#780Synthesis of epothilones, intermediates thereto, analogues and uses thereof
#781METHODS OF IMPROVING QUALITY OF SLEEP
#782DIRECT DRUG DELIVERY SYSTEM BASED ON THERMALLY RESPONSIVE BIOPOLYMERS
#783Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents
#784PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM
#785Antibody therapy
#786COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC)
#787Compliant composites for application of drug-eluting coatings to tissue surfaces
#788Folate receptor binding conjugates of antifolates
#789PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM
#790COMPOSITIONS AND METHODS USING ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE MYELOMA
#791USE OF CNS PENETRATING ANTICANCER COMPOUNDS FOR THE TREATMENT OF PROTOZOAL DISEASES
#792Particulate drug carriers as desensitizing agents
#793Compositions for delivering highly water soluble drugs
#794NOVEL TREATMENT OF HEART DISEASES
#795Multiple myeloma treatments
#796Methods and compositions for treating a disease condition in a subject
#797PHARMACEUTICAL COMPOSITION OF VINFLUNINE WHICH IS INTENDED FOR PARENTERAL ADMINISTRATION PREPARATION METHOD THEREOF AND USE OF SAME
#798Cephalotaxine Alkaloid Compositions and Uses Thereof
#799Bioactive composition for the treatment of the HIV/AIDS, method for manufacturing and using the same
#800USES OF ANTI-CD40 ANTIBODIES
#801Combinations of Organic Compounds
#802PSMA binding ligand-linker conjugates and methods for using
#803NOVEL COMPOSITION FOR TREATING THE SIDE EFFECTS OF ANTICANCER TREATMENTS
#804COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC)
#805Alkanoylamino benzamide aniline HDAC inhibitor compounds
#806USE OF NOVEL NEUROPROTECTIVE 3-SUBSTITUTED INDOLONE COMPOSITIONS
#807ANTAGONIST AGAINST TOLERANCE TO ANTICANCER DRUGS
#808Aqueous solution of conophylline and/or conophyllidine
#809Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
#810Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
#811Ellipticine compounds for treating obesity
#812Cancer Treatment Method
#813SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO, ANALOGUES AND USES THEREOF
#814Chemotherapeutic for inducing an MSH2-dependent apoptotic pathway
#815Antibody therapy
#816Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents
#817Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
#818METHODS AND COMPOSITIONS FOR MODULATING INSULIN SECRETION AND GLUCOSE METABOLISM
#819Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt
#820STABLE PHARMACEUTICAL COMPOSITION OF A WATER-SOLUBLE VINORELBINE SALT
#821Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
#822TREATMENT OF NEOPLASTIC DISORDERS USING COMBINATION THERAPIES
#823KLOTHO BETA
#824Anticancer Agent to Be Combined with Telomelysin
#825NOVEL TETRAHYDRO-1H-PYRIDO[4,3-B]INDOLES
#826Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
#827PHARMACEUTICAL COMPOSITION
#828Methods and Compositions Using Immunomodulatory Compounds for The Treatment and Management of Cancers and Other Diseases
#829HYDROGENATED PYRIDO (4,3-B) INDOLES FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
#830Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors
#831Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor
#832Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature
#833MODULATION OF NITRIC OXIDE SIGNALING TO NORMALIZE TUMOR VASCULATURE
#834Weight loss compositions and uses thereof
#835Drug loaded polymeric nanoparticles and methods of making and using same
#836Drug loaded polymeric nanoparticles and methods of making and using same
#837METHODS FOR TREATMENT OF COLORECTAL CANCER USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE
#838Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea
#839Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
#840Antineoplastic Combinations Containing HKI-272 and Vinorelbine
#841Second line treatment of metastatic hormone refractory prostate cancer using satraplatin
#842Compositions And Methods For Reversing Or Preventing Resistance Of A Cancer Cell To A Cytotoxic Agent
#843USE OF INTERLEUKIN-19 TO TREAT CERVICAL CANCER
#844THERAPY FOR HUMAN CANCERS USING CISPLATIN AND OTHER DRUGS OR GENES ENCAPSULATED INTO LIPOSOMES
#845METHODS AND COMPOSITIONS FOR PROMOTING ACTIVITY OF ANTI-CANCER THERAPIES
#846Method of treating cancer by co-administration of anticancer agents
#847COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC)
#848Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
#849Composition and methods for weight loss in a subject
#850Treatment of sepsis and inflammation with alphaadrenergic antagonists
#851REVERSION OF MALIGNANT PHENOTYPE WITH 9-HYDROXY ELLIPTICINE DERIVATIVES
#852Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies
#853Combination anticancer agents
#854Method for preventing and/or treating peripheral Neuropathies induced by the administration of an anticancer agent
#855Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
#856Intestinal absorptive anti-tumor agent
#857Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
#858METHODS FOR THE TREATMENT OF BLADDER CANCER USING 3-(4-AMINO-1-OXO-1,3-DIHYDROISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE
#859Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
#860COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER
#861Treatment of tinnitus
#862Antibody therapy
#863Potentiation of anticancer agents
#864Nano anticancer micelles of vinca alkaloids entrapped in polyethylene glycolylated phospholipids
#865Compositions and methods for treating lymphoma
#866RETROVIRAL IMMUNOTHERAPY
#867COMPOSITIONS AND METHODS FOR TREATING LYMPHOMA
#868Methods for treatment prostate cancer using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
#869Combinations of Organic Compounds
#870Methods for treating head or neck cancer using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
#871Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
#872Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantation
#873Methods for treating sarcoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione
#874Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent
#875Sparc Promoter Mutations Associated with Drug Resistance, and Methods, Oligonucleotides, Cells and Arrays Associated Therewith
#876Antagonist Against Tolerance to Anticancer Drugs
#877Indibulin therapy
#878Method of producing medicinal nanoparticle suspension
#879Methods for treating brain cancer using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione
#880Methods for treatment of behcet's disease using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
#881Combination Therapies Using Hdac Inhibitors
#882Deuterium Depleted Water (Ddw) Using As Adjuvant In Cancer Therapy For Cytostatics Toxicity Reducing
#883Treatment of Epilepsy
#884Use of Nordihydroguaiaretic Acid Derivatives in the Treatment of Drug Resistant Cancer, Viral and Microbial Infection
#885Method for treatment and management of thyroid cancer using immunomodulatory compounds
#886Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline
#887Medicament for preventing and/or treating peripheral neuropathies
#888TREATMENT OF BRAIN DISORDERS OF THE STRIATUM
#889Triazole compounds that modulate Hsp90 activity
#890Method of treating cancer by co-administration of anticancer agents
#891Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy
#892Compositions and methods for treating or preventing imflammatory diseases
#893Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis
#894Antitumor Agent
#895Compositions and methods using anti-CS1 antibodies to treat multiple myeloma
#896Compositions and methods for treating or preventing inflammatory diseases
#897Dietary supplement and a method to enhance sleep and lucid dreaming
#898Anti-cancer combinations
#899Anti-cancer combinations
#900Anti-cancer combinations